GLP-1 medications work like an upgraded factory supervisor who coordinates multiple departments at once: Pancreas (Smart Insulin Release): Stimulates insulin only when blood sugar is high stops when sugar normalizes low risk of hypoglycemia (unlike older drugs) Brain (Appetite Control): Acts on hypothalamus & brainstem reduces food cravings food loses emotional grip Stomach (Slow Emptying): Delays gastric emptying smaller meals keep you full longer Liver (Reduced Sugar Output): Suppresses glucagon lowers excessive glucose release from liver improves fasting blood sugar (especially beneficial for insulin-resistant individuals, common in Indian populations) Beyond Blood Sugar (Multi-Organ Effects): GLP-1 receptors found in heart, blood vessels, kidneys, brain being studied for heart failure, kidney disease, fatty liver (NAFLD/NASH), Parkinsons, and Alzheimers GLP-1 Medications List: Names, Forms, and Costs in India (2026) Important note: Oral semaglutide (Rybelsus) is currently approved in India only for Type 2 diabetes, not for weight loss
A new study in JAMA uses real-world evidence that complements these trials
Have You Felt The Glutathione Glow
They showed that semaglutide enhanced histological parameters of fibrosis and inflammation while decreasing hepatic expression of genes associated with fibrotic and inflammatory cascade: through proteomic profiling of serum from MASH patients treated with semaglutide, they detected 72 proteins linked to disease resolution and validated these findings in preclinical mouse models and an independent patient cohort [28]
It is also shown to promote angiogenesis, cellular repair, and tissue growth in many organs while modulating inflammatory response [1, 2, 3]
